Lu R, Zhao X, Li J, Niu P, Yang B, Wu H,
et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565-74.
2.
Yang Z, Wang M, Zhu Z, Liu Y. Coronavirus disease 2019 (COVID-19) and pregnancy: A systematic review. J Matern Fetal Neonatal Med 2020;33:1-4.
3.
Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M,
et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: A systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020;2:100107.
4.
Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F,
et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis 2020;20:e238-44.
5.
Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J,
et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J Pathol 2004;203:622-30.
6.
Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol 2020;92:568-76.
7.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y,
et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
8.
Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G,
et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis 2020;96:19-24.
9.
Sriram K, Insel PA. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance. Br J Pharmacol 2020;177:4825-44.
10.
Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol Res 2020;157:104833.
11.
Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ,
et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020;251:228-48.
12.
Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 2020;76:14-20.
13.
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B,
et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005;11:875-9.
14.
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G,
et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020;323:1843-4.
15.
Fu J, Zhou B, Zhang L, Balaji KS, Wei C, Liu X,
et al. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep 2020;47:4383-92.
16.
Domińska K. Involvement of ACE2/Ang-(1-7)/MAS1 axis in the regulation of ovarian function in mammals. Int J Mol Sci 2020;21:4572.
17.
Palumbo A, Ávila J, Naftolin F. The Ovarian Renin-Angiotensin system (OVRAS): A major factor in ovarian function and disease. Reprod Sci 2016;23:1644-55.
18.
Vinson GP, Saridogan E, Puddefoot JR, Djahanbakhch O. Tissue renin-angiotensin systems and reproduction. Hum Reprod 1997;12:651-62.
19.
Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G,
et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod 2020;26:367-73.
20.
Li R, Yin T, Fang F, Li Q, Chen J, Wang Y,
et al. Potential risks of SARS-CoV-2 infection on reproductive health. Reprod Biomed Online 2020;41:89-95.
21.
Mahdian S, Shahhoseini M, Moini A. COVID-19 mediated by Basigin can affect male and female fertility. Int J Fertil Steril 2020;14:262-3.
22.
Henarejos-Castillo I, Sebastian-Leon P, Devesa-Peiro A, Pellicer A, Diaz-Gimeno P. SARS-CoV-2 infection risk assessment in the endometrium: Viral infection-related gene expression across the menstrual cycle. Fertil Steril 2020;114:223-32.
23.
Abhari S, Kawwass JF. Endometrial susceptibility to SARS CoV-2: Explained by gene expression across the menstrual cycle? Fertil Steril 2020;114:255-6.
24.
Segars J, Katler Q, McQueen DB, Kotlyar A, Glenn T, Knight Z,
et al. Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: What is known? Fertil Steril 2020;113:1140-9.
25.
Pozzilli P, Lenzi A. Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic. Metabolism 2020;108:154252.
26.
Dutta S, Sengupta P. SARS-CoV-2 and male infertility: possible multifaceted pathology. Reprod Sci 2021;28:23-6.
27.
Huang C, Ji X, Zhou W, Huang Z, Peng X, Fan L,
et al. Coronavirus: A possible cause of reduced male fertility. Andrology 2021;9:80-7.
28.
Bridwell RE, Merrill DR, Griffith SA, Wray J, Oliver JJ. A coronavirus disease 2019 (COVID-19) patient with bilateral orchitis. Am J Emerg Med 2021;42:260.e3-5.
29.
Delle Fave RF, Polisini G, Giglioni G, Parlavecchio A, Dell'Atti L, Galosi AB. COVID-19 and male fertility: Taking stock of one year after the outbreak began. Arch Ital Urol Androl 2021;93:115-9.
30.
Ma L, Xie W, Li D, Shi L, Ye G, Mao Y,
et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J Med Virol 2021;93:456-62.
31.
Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D,
et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology 2021;9:88-98.
32.
Schroeder M, Tuku B, Jarczak D, Nierhaus A, Bai T, Jacobsen H,
et al. The majority of male patients with COVID-19 present low testosterone levels on admission to Intensive Care in Hamburg, Germany: A retrospective cohort study. medRxiv 2020;2020:1-23.
33.
Illiano E, Trama F, Costantini E. Could COVID-19 have an impact on male fertility? Andrologia 2020;52:e13654.
34.
Mills IG. Maintaining and reprogramming genomic androgen receptor activity in prostate cancer. Nat Rev Cancer 2014;14:187-98.
35.
Li K, Chen G, Hou H, Liao Q, Chen J, Bai H,
et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod Biomed Online 2021;42:260-7.
36.
Pan F, Xiao X, Guo J, Song Y, Li H, Patel DP,
et al. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril 2020;113:1135-9.
37.
Yang M, Chen S, Huang B, Zhong JM, Su H, Chen YJ,
et al. Pathological findings in the testes of COVID-19 patients: Clinical implications. Eur Urol Focus 2020;6:1124-9.
38.
Xu J, Qi L, Chi X, Yang J, Wei X, Gong E,
et al. Orchitis: A complication of severe acute respiratory syndrome (SARS). Biol Reprod 2006;74:410-6.
39.
Oncel MY, Akın IM, Kanburoglu MK, Tayman C, Coskun S, Narter F,
et al. A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society. Eur J Pediatr 2021;180:733-42.
40.
Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S,
et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet 2020;150:47-52.
41.
Danza Á, Ruiz-Irastorza G, Khamashta M. Pregnancy in systemic autoimmune diseases: Myths, certainties and doubts. Med Clin (Barc) 2016;147:306-12.
42.
Zoller AL, Schnell FJ, Kersh GJ. Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration. Immunology 2007;121:207-15.
43.
Kraus TA, Engel SM, Sperling RS, Kellerman L, Lo Y, Wallenstein S,
et al. Characterizing the pregnancy immune phenotype: Results of the viral immunity and pregnancy (VIP) study. J Clin Immunol 2012;32:300-11.
44.
Dashraath P, Wong JL, Lim MX, Lim LM, Li S, Biswas A,
et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020;222:521-31.
45.
Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH,
et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004;136:95-103.
46.
Thevarajan I, Nguyen TH, Koutsakos M, Druce J, Caly L, van de Sandt CE,
et al. Breadth of concomitant immune responses prior to patient recovery: A case report of non-severe COVID-19. Nat Med 2020;26:453-5.
47.
Littauer EQ, Esser ES, Antao OQ, Vassilieva EV, Compans RW, Skountzou I. H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation. PLoS Pathog 2017;13:e1006757.
48.
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W,
et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet 2020;395:809-15.
49.
Hsu AL, Guan M, Johannesen E, Stephens AJ, Khaleel N, Kagan N,
et al. Placental SARS-CoV-2 in a pregnant woman with mild COVID-19 disease. J Med Virol 2021;93:1038-44.
50.
Fenizia C, Biasin M, Cetin I, Vergani P, Mileto D, Spinillo A,
et al. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat Commun 2020;11:5128.
51.
Lee WY, Mok A, Chung JPW. Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: A review. Hong Kong Med J 2021;27:118-26.
52.
Yart L, Roset Bahmanyar E, Cohen M, Martinez de Tejada B. Role of the uteroplacental renin-angiotensin system in placental development and function, and its implication in the preeclampsia pathogenesis. Biomedicines 2021;9:1332.
53.
Guo TH, Sang MY, Bai S, Ma H, Wan YY, Jiang XH,
et al. Semen parameters in men recovered from COVID-19. Asian J Androl 2021;23:479-83.
[
PUBMED]
[Full text]
54.
He M, Skaria P, Kreutz K, Chen L, Hagemann IS, Carter EB,
et al. Histopathology of third trimester placenta from SARS-CoV-2-positive women. Fetal Pediatr Pathol 2020;1:1-10.
55.
Penfield CA, Brubaker SG, Limaye MA, Lighter J, Ratner AJ, Thomas KM,
et al. Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples. Am J Obstet Gynecol MFM 2020;2:100133.
56.
Lumbers ER. The physiological roles of the renin-angiotensin aldosterone system and vasopressin in human pregnancy. In: Maternal-Fetal and Neonatal Endocrinology. Canada: Academic Press; 2020. p. 129-45.
57.
Blumenfeld Z. Possible impact of COVID-19 on fertility and assisted reproductive technologies. Fertil Steril 2020;114:56-7.
58.
Pinto D, Park Y, Beltramello M, Walls AC, Tortorici MA, Bianchi S,
et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 2020;583:290-295.
59.
Blasco Santana L, Miraval Wong E, Álvarez-Troncoso J, Sánchez García L, Bartha JL, Regojo-Zapata RM. Maternal and perinatal outcomes and placental pathologic examination of 29 SARS-CoV-2 infected patients in the third trimester of gestation. J Obstet Gynaecol Res 2021;47:2131-9.
60.
Prochaska E, Jang M, Burd I. COVID-19 in pregnancy: Placental and neonatal involvement. Am J Reprod Immunol 2020;84:e13306.
61.
Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease-19 and fertility: Viral host entry protein expression in male and female reproductive tissues. Fertil Steril 2020;114:33-43.
62.
Vahed SZ, Ghiyasvand S, Tolouian R, Noshad H, Tolouian AC, Shoja MM,
et al. The footprint of androgen sensitive serine protease (TMPRSS2) in gender mortality with COVID-19. Immunopathologia Persa 2020;6:3-4.
63.
Bhattacharya K, Mukhopadhyay LD, Goswami R, Dutta S, Sengupta P, Irez T,
et al. SARS-CoV-2 infection and human semen: Possible modes of contamination and transmission. Middle East Fertil Soc J 2021;26:18.
64.
Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O,
et al. Assessment of SARS-CoV-2 in human semen-a cohort study. Fertil Steril 2020;114:233-8.
65.
Erbay G, Sanli A, Turel H, Yavuz U, Erdogan A, Karabakan M,
et al. Short-term effects of COVID-19 on semen parameters: A multicenter study of 69 cases. Andrology 2021;9:1060-5.